(Q35128618)

6 August 2017

1 reference

title

Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma (English)

1 reference

6 August 2017

0 references

Howard A Ball

1

1 reference

6 August 2017

Anthony Sandrasagra

2

1 reference

6 August 2017

Lei Tang

3

1 reference

6 August 2017

Mike Van Scott

4

1 reference

6 August 2017

James Wild

5

1 reference

6 August 2017

Jonathan W Nyce

6

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Molecular Diagnosis and Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

97-106

1 reference

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Pharmacogenomics of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Haloperidol-induced tardive dyskinesia in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

Familial occurrence of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500152

21 January 2018

Identifiers

DOI

10.1038/SJ.TPJ.6500152

1 reference

6 August 2017

1 reference